Betaleukin (human recombinant interleukin-1 beta) --a new effective leukopoiesis stimulant and protector in the combined chemotherapy of malignant tumors
Gershanovich, M.L.; Filatova, L.V.; Ketlinskiĭ, S.A.; Simbirtsev, A.S.
Voprosy Onkologii 46(3): 354-360
2000
ISSN/ISBN: 0507-3758 PMID: 10976287 Document Number: 514076
Document emailed within 1 workday
Related Documents
Gershanovich, M.L.; Ketlinskiĭ, S.A.; Filatova, L.V.; Danova, L.A.; Korolenko, V.O.; Simbirtsev, A.S. 1996: Stimulating and protective effect of recombinant interleukin-1-beta (beta-leukin) on leukopoiesis in chemotherapy of malignant tumors Voprosy Onkologii 42(6): 13-18Enomoto, H.; Yoshida, J.; Kageyama, N.; Ueda, R.; Kato, T.; Ota, K. 1986: Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1953-1961
Nemunaitis, J.; Ross, M.; Meisenberg, B.; O'Reilly, R.; Lilleby, K.; Buckner, C.D.; Appelbaum, F.R.; Buhles, W.; Singer, J.; Peters, W.P. 1994: Phase i study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure Bone Marrow Transplantation 14(4): 583-588
Espevik, T.; Figari, I.S.; Ranges, G.E.; Palladino, M.A. 1988: Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1 Journal of Immunology 140(7): 2312-2316
Lachman, L.B.; Dinarello, C.A.; Llansa, N.D.; Fidler, I.J. 1986: Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells Journal of Immunology 136(8): 3098-3102
Geiger, T.; Rordorf, C.; Galakatos, N.; Seligmann, B.; Henn, R.; Lazdins, J.; Erard, F.; Vosbeck, K. 1992: Recombinant human C5a induces transcription but not translation of interleukin 1 beta mRNA in human monocytes Lymphokine and Cytokine Research 11(1): 55-63
Stabel, J.R.; Kehrli, M.E.; Goff, J.P. 1993: Enhancement of lymphocyte function and interleukin 1 beta transcription by recombinant bovine interleukin 1 beta American Journal of Veterinary Research 54(1): 86-91
Kudo, S.; Mizuno, K.; Hirai, Y.; Shimizu, T. 1990: Clearance and tissue distribution of recombinant human interleukin 1 beta in rats Cancer Research 50(18): 5751-5755
Nonomura, K.; Shinohara, N.; Shinno, Y.; Seki, T.; Koyanagi, T.; Nagamori, S.; Fujieda, J.; Togashi, M.; Ohashi, N.; Abe, N.; Toyota, K.; Maru, A.; Gotoh, T.; Sakakibara, N.; Sakashita, S.; Kosugi, M.; Adachi, Y. 1996: Effective administration of recombinant granulocyte colony-stimulating factor to prevent granulocytopenia due to combination chemotherapy for testicular germ cell tumors Hinyokika Kiyo. Acta Urologica Japonica 42(9): 699-704
Mameya, S.; Sawa, T.; Taniyama, K. 1995: Arachidonic acid cascade and stimulation of acetylcholine release by human recombinant interleukin-1 beta in guinea pig ileum Journal of Pharmacology and Experimental Therapeutics 275(1): 319-324
Wang, Q.L. 1989: Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors Zhonghua Zhong Liu Za Zhi 11(3): 222-225
Itoh, K.; Shiiba, K.; Ebina, N.; Anzai, R.; Ouchi, A.; Matsuno, S. 1993: Functional and phenotypic analysis of tumor infiltrating lymphocytes derived from solid tumors and effusion associated lymphocytes in malignant ascites cultured in recombinant interleukin 2 Nihon Geka Gakkai Zasshi 94(8): 781-790
Chizh, G.I.; Bordiushkov, I.N.; Tkacheva, L.A.; Maliutina, L.I.; Taradin, L.V. 1976: Adequate regional chemotherapy in combined treatment of malignant tumors of the nose and nasal sinuses Vestnik Otorinolaringologii 1976(1): 76-80
Ottmann, O.G.; Abboud, M.; Welte, K.; Souza, L.M.; Pelus, L.M. 1989: Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors Experimental Hematology 17(2): 191-197
Orekhovich, V.N.; Abakumova, O.I.; Kazakova, O.V.; Lerman, M.I. 1977: Proteinases and chemotherapy of malignant human tumors Vestnik Akademii Meditsinskikh Nauk SSSR 10: 24-29
Réglier-Poupet, H.; Hakim, J.; Gougerot-Pocidalo, M.A.; Elbim, C. 1998: Absence of regulation of human polymorphonuclear oxidative burst by interleukin-10, interleukin-4, interleukin-13 and transforming growth factor-beta in whole blood European Cytokine Network 9(4): 633-638
Ikebuchi, Y.; Shimizu, H.; Moriyama, A.; Kubota, Y.; Nohara, A.; Nishimura, Y. 1995: Autologous blood transfusion with recombinant human erythropoietin and hypotensive anesthesia in operation for gynecological malignant tumors Nihon Sanka Fujinka Gakkai Zasshi 47(2): 169-172
Radeke, H.H.; Martin, M.; Topley, N.; Kaever, V.; Resch, K. 1991: Differential biological activities of human interleukin-1 alpha and interleukin-1 beta European Cytokine Network 2(1): 51-59
Furuse, K.; Morimoto, K.; Yamamoto, K.; Orito, T. 1989: Application of preoperative chemotherapy to postoperative chemotherapy in malignant bone and soft tissue tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-3): 1749-1754
Bisenkov, L.N.; Simbirtsev, A.S.; Zolotarev, D.V.; Salamatov, A.V.; Variushina, E.A. 2001: Local use of recombinant interleukin-1 beta in the complex treatment of patients with acute lung abscess Vestnik Khirurgii Imeni I. I. Grekova 160(3): 20-24